Introduction
Thirty years of contrast enhanced breast MRI.- The mantra about low specificity breast MRI.- BRCA and other genes conferring hereditary breast cancer predisposition.- Screening mammography: One size fits all?.- MRI protocols for breast cancer screening.- Contrast materials for screening MRI and concerns about tissue deposition
Applying MRI BI-RADS in a high-risk population
CAD systems for breast MRI screening
Phenotype presentation and radiogenomics of breast cancer with special focus on high-risk women.- The body of primary evidence about MRI for high risk screening: retrospective and prospective studies.- High-risk screening: MRI alone?.- Secondary evidence from systematic reviews and meta-analyses.- Radioprotection issues for women with hereditary predisposition for breast cancer.- Impact of MRI screening on high-risk patient outcome.- The special case of previous chest radiation therapy.- IT infrastructure for data managing in multicenter high-risk screening.- Guidelines and recommendations all over the world: agreements and differences
Medical options: Pharmacopreventio- Surgical options: Prophylactic mastectomy and oophorectomy.- Psychosocial aspects of high-risk of breast cancer.- Calculating, using and improving individual breast cancer risk estimates
MRI for screening women with a personal history of breast cancer.- Screening MRI for the intermediate risk: an open issue
Looking at the future: Personalized breast cancer screening.- Acknowledgments.
Sardanelli, Francesco
Podo, Franca
ISBN | 978-3-030-41206-7 |
---|---|
Artikelnummer | 9783030412067 |
Medientyp | Buch |
Auflage | 1st ed. 2020 |
Copyrightjahr | 2020 |
Verlag | Springer, Berlin |
Umfang | XXIII, 376 Seiten |
Abbildungen | XXIII, 376 p. 84 illus., 32 illus. in color. |
Sprache | Englisch |